24th Apr 2014 12:16
LONDON (Alliance News) - <strong>AstraZeneca</strong> shares jumped Thursday after the pharmaceutical giant maintained its full-year guidance for 2014, even as its pretax profit dropped in the first quarter to end-March, hit by write-downs on the sale of its Alderley Park site and its acquisit Read More
